Friday, 26 January 2018

CHMP Backs Emicizumab for Hemophilia A With Factor VIII Inhibitors

  1. CHMP Backs Emicizumab for Hemophilia A With Factor VIII Inhibitors  MedscapeFull coverage

No comments:

Post a Comment